Stocktake of PBS medicines available for endometriosis and related conditions Report

In December 2022, the Pharmaceutical Benefits Advisory Committee considered the ‘Stocktake of PBS medicines available for endometriosis and related conditions, and comparison of current Australian pharmacological treatment guidelines’ Report. The Report (PDF 620 KB)-(Word 81 KB) and a Consumer Summary (PDF 285 KB)-(Word 135 KB) are now available.

If you have any questions relating to the Report or Consumer Summary, please email PBSpostmarket@health.gov.au